The REDUCE trial found that a common blood pressure medication, added to standard post-stroke care, helps more people keep their blood pressure within the target range, but does not prove a reduction in repeat strokes.
Spironolactone Helps More Post-Stroke Patients Hit Blood Pressure Target
The REDUCE trial found that a common blood pressure medication, added to standard post-stroke care, helps more people keep their blood pressure within the target range, but does not prove a reduction in repeat strokes.
This item was produced with AI assistance under the editorial responsibility of Haydamax OÜ.
Monitoring item. The full text is not distributed. Extract and source below.
Same event, other desks
Story file →
fr
Danny Boyle affirme qu'un troisième « 28 Years Later » devra être financé par ses propres moyens
15.11 04:30
fr
La Danoise Mathilde Arcel, primée à Venise, se confie sur sa vie après son triomphe au Lido
15.11 13:30